KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $1.6 billion.

  • Edwards Lifesciences' Total Current Liabilities fell 1831.7% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year decrease of 1831.7%. This contributed to the annual value of $1.5 billion for FY2024, which is 2591.6% up from last year.
  • As of Q3 2025, Edwards Lifesciences' Total Current Liabilities stood at $1.6 billion, which was down 1831.7% from $1.4 billion recorded in Q2 2025.
  • In the past 5 years, Edwards Lifesciences' Total Current Liabilities registered a high of $1.9 billion during Q3 2024, and its lowest value of $799.0 million during Q1 2021.
  • Its 5-year average for Total Current Liabilities is $1.2 billion, with a median of $1.1 billion in 2024.
  • Per our database at Business Quant, Edwards Lifesciences' Total Current Liabilities skyrocketed by 5692.15% in 2024 and then tumbled by 1831.7% in 2025.
  • Over the past 5 years, Edwards Lifesciences' Total Current Liabilities (Quarter) stood at $1.0 billion in 2021, then fell by 0.96% to $1.0 billion in 2022, then grew by 16.92% to $1.2 billion in 2023, then grew by 25.92% to $1.5 billion in 2024, then increased by 5.5% to $1.6 billion in 2025.
  • Its Total Current Liabilities stands at $1.6 billion for Q3 2025, versus $1.4 billion for Q2 2025 and $1.4 billion for Q1 2025.